ID   CTGF_HUMAN              Reviewed;         349 AA.
AC   P29279; E1P578; Q6LCY0; Q96A79; Q96QX2; Q9UDL6;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=Connective tissue growth factor;
DE   AltName: Full=CCN family member 2;
DE   AltName: Full=Hypertrophic chondrocyte-specific protein 24;
DE   AltName: Full=Insulin-like growth factor-binding protein 8;
DE            Short=IBP-8;
DE            Short=IGF-binding protein 8;
DE            Short=IGFBP-8;
DE   Flags: Precursor;
GN   Name=CTGF; Synonyms=CCN2, HCS24, IGFBP8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-83.
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=1654338; DOI=10.1083/jcb.114.6.1285;
RA   Bradham D.M., Igarashi A., Potter R.L., Grotendorst G.R.;
RT   "Connective tissue growth factor: a cysteine-rich mitogen secreted by
RT   human vascular endothelial cells is related to the SRC-induced
RT   immediate early gene product CEF-10.";
RL   J. Cell Biol. 114:1285-1294(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-83.
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=1293144; DOI=10.1111/j.1346-8138.1992.tb03748.x;
RA   Igarashi A., Bradham D.M., Okochi H., Grotendorst G.R.;
RT   "Connective tissue growth factor.";
RL   J. Dermatol. 19:642-643(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-83.
RC   TISSUE=Aorta;
RX   PubMed=9054739; DOI=10.1161/01.CIR.95.4.831;
RA   Oemar B.S., Werner A., Garnier J.-M., Do D.D., Godoy N., Nauck M.,
RA   Marz W., Rupp J., Pech M., Luescher T.F.;
RT   "Human connective tissue growth factor is expressed in advanced
RT   atherosclerotic lesions.";
RL   Circulation 95:831-839(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ASP-83.
RA   Li Q.-H., Wang L.-C., Liu L.-D., Dong S.-Z., Wang J.-J., Hu F.,
RA   Wang J., He S.-Q., Dong C.-H., Zhao S.-D., Zhao H.-L.;
RT   "Expression, purification and bio-activity of human connective tissue
RT   growth factor.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ASP-83.
RC   TISSUE=Liver;
RA   Dai W.-J., Jiang H.-C., Fu S.-B.;
RT   "Complete mRNA sequence of human connective tissue growth factor.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-83.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-83.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-20.
RC   TISSUE=Placenta;
RA   Xin L.W., Martinerie C., Zumkeller W., Westphal M., Perbal B.;
RT   "Differential expression of novH and CTGF in human glioma cell
RT   lines.";
RL   Clin. Mol. Pathol. 49:91-97(1996).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-20.
RA   Blom I.E., van Dijk A.J., de Weger R.A., Tilanus M.G.J.,
RA   Goldschmeding R.;
RT   "Identification of human CCN2 (connective tissue growth factor)
RT   promoter polymorphisms.";
RL   J. Clin. Pathol. 54:192-196(2001).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 75-349, AND VARIANT ASP-83.
RA   Cody C.W., Walker N.J., Greenlee W.F., Sutter T.R.;
RT   "Connective tissue growth factor mRNA is expressed in human
RT   keratinocytes as an immediate early gene that responds to serum, EGF,
RT   or wounding.";
RL   Submitted (SEP-1994) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 99-176 AND 204-225 (ISOFORM 1), AND
RP   TISSUE SPECIFICITY.
RX   PubMed=1756408;
RA   Martinerie C., Perbal B.;
RT   "Expression of a gene encoding a novel potential IGF binding protein
RT   in human tissues.";
RL   C. R. Acad. Sci. III, Sci. Vie 313:345-351(1991).
RN   [14]
RP   FUNCTION.
RC   TISSUE=Chondrocyte;
RX   PubMed=10614647; DOI=10.1210/endo.141.1.7267;
RA   Nakanishi T., Nishida T., Shimo T., Kobayashi K., Kubo T.,
RA   Tamatani T., Tezuka K., Takigawa M.;
RT   "Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-
RT   specific gene, on the proliferation and differentiation of
RT   chondrocytes in culture.";
RL   Endocrinology 141:264-273(2000).
RN   [15]
RP   HEPARIN-BINDING, AND FUNCTION IN CELL ADHESION.
RX   PubMed=12553878; DOI=10.1677/joe.0.176R001;
RA   Ball D.K., Rachfal A.W., Kemper S.A., Brigstock D.R.;
RT   "The heparin-binding 10 kDa fragment of connective tissue growth
RT   factor (CTGF) containing module 4 alone stimulates cell adhesion.";
RL   J. Endocrinol. 176:R1-R7(2003).
CC   -!- FUNCTION: Major connective tissue mitoattractant secreted by
CC       vascular endothelial cells. Promotes proliferation and
CC       differentiation of chondrocytes. Mediates heparin- and divalent
CC       cation-dependent cell adhesion in many cell types including
CC       fibroblasts, myofibroblasts, endothelial and epithelial cells.
CC       Enhances fibroblast growth factor-induced DNA synthesis.
CC       {ECO:0000269|PubMed:10614647, ECO:0000269|PubMed:12553878}.
CC   -!- SUBUNIT: Monomer.
CC   -!- INTERACTION:
CC       P02751:FN1; NbExp=5; IntAct=EBI-2835375, EBI-1220319;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250}. Secreted {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Long;
CC         IsoId=P29279-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P29279-2; Sequence=VSP_002460;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in bone marrow and thymic cells.
CC       Also expressed one of two Wilms tumors tested.
CC       {ECO:0000269|PubMed:1756408}.
CC   -!- SIMILARITY: Belongs to the CCN family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CTGFID40192ch6q23.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M92934; AAA91279.1; -; mRNA.
DR   EMBL; X78947; CAA55544.1; -; mRNA.
DR   EMBL; AY395801; AAQ95223.1; -; mRNA.
DR   EMBL; AY550024; AAS55639.1; -; mRNA.
DR   EMBL; BT019794; AAV38597.1; -; mRNA.
DR   EMBL; BT019795; AAV38598.1; -; mRNA.
DR   EMBL; CR541759; CAG46559.1; -; mRNA.
DR   EMBL; AL354866; CAC44023.1; -; Genomic_DNA.
DR   EMBL; X92511; CAA63267.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48038.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48039.1; -; Genomic_DNA.
DR   EMBL; AF316366; AAK60505.1; -; Genomic_DNA.
DR   EMBL; AF316367; AAK60506.1; -; Genomic_DNA.
DR   EMBL; AF316368; AAK60507.1; -; Genomic_DNA.
DR   EMBL; U14750; AAA75378.1; -; mRNA.
DR   CCDS; CCDS5151.1; -. [P29279-1]
DR   PIR; A40551; A40551.
DR   RefSeq; NP_001892.1; NM_001901.2.
DR   UniGene; Hs.410037; -.
DR   ProteinModelPortal; P29279; -.
DR   BioGrid; 107872; 13.
DR   IntAct; P29279; 15.
DR   MINT; MINT-1779737; -.
DR   STRING; 9606.ENSP00000356954; -.
DR   iPTMnet; P29279; -.
DR   PhosphoSitePlus; P29279; -.
DR   BioMuta; CTGF; -.
DR   DMDM; 116241320; -.
DR   EPD; P29279; -.
DR   MaxQB; P29279; -.
DR   PaxDb; P29279; -.
DR   PeptideAtlas; P29279; -.
DR   PRIDE; P29279; -.
DR   DNASU; 1490; -.
DR   Ensembl; ENST00000367976; ENSP00000356954; ENSG00000118523. [P29279-1]
DR   GeneID; 1490; -.
DR   KEGG; hsa:1490; -.
DR   UCSC; uc003qcz.4; human. [P29279-1]
DR   CTD; 1490; -.
DR   DisGeNET; 1490; -.
DR   GeneCards; CTGF; -.
DR   HGNC; HGNC:2500; CTGF.
DR   HPA; CAB005123; -.
DR   HPA; HPA031074; -.
DR   HPA; HPA031075; -.
DR   MalaCards; CTGF; -.
DR   MIM; 121009; gene.
DR   neXtProt; NX_P29279; -.
DR   OpenTargets; ENSG00000118523; -.
DR   Orphanet; 220393; Diffuse cutaneous systemic sclerosis.
DR   Orphanet; 220402; Limited cutaneous systemic sclerosis.
DR   PharmGKB; PA27003; -.
DR   eggNOG; ENOG410IH0W; Eukaryota.
DR   eggNOG; ENOG4111F77; LUCA.
DR   GeneTree; ENSGT00760000119225; -.
DR   HOGENOM; HOG000231462; -.
DR   HOVERGEN; HBG000635; -.
DR   InParanoid; P29279; -.
DR   KO; K06827; -.
DR   OMA; KCIRTPR; -.
DR   OrthoDB; EOG091G0SQP; -.
DR   PhylomeDB; P29279; -.
DR   TreeFam; TF326070; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2032785; YAP1- and WWTR1 (TAZ)-stimulated gene expression.
DR   SIGNOR; P29279; -.
DR   ChiTaRS; CTGF; human.
DR   GeneWiki; CTGF; -.
DR   GenomeRNAi; 1490; -.
DR   PRO; PR:P29279; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000118523; -.
DR   CleanEx; HS_CTGF; -.
DR   Genevisible; P29279; HS.
DR   GO; GO:0005938; C:cell cortex; IEA:Ensembl.
DR   GO; GO:0005801; C:cis-Golgi network; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:ProtInc.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; TAS:ProtInc.
DR   GO; GO:0001968; F:fibronectin binding; IEA:Ensembl.
DR   GO; GO:0008083; F:growth factor activity; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005520; F:insulin-like growth factor binding; TAS:ProtInc.
DR   GO; GO:0005178; F:integrin binding; IEA:Ensembl.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0001502; P:cartilage condensation; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; IEA:Ensembl.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0035988; P:chondrocyte proliferation; IEA:Ensembl.
DR   GO; GO:0060401; P:cytosolic calcium ion transport; IEA:Ensembl.
DR   GO; GO:0071897; P:DNA biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0070278; P:extracellular matrix constituent secretion; IEA:Ensembl.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0060548; P:negative regulation of cell death; IEA:Ensembl.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0001503; P:ossification; IEA:Ensembl.
DR   GO; GO:0060452; P:positive regulation of cardiac muscle contraction; IEA:Ensembl.
DR   GO; GO:0050867; P:positive regulation of cell activation; IEA:Ensembl.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL.
DR   GO; GO:0070318; P:positive regulation of G0 to G1 transition; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:BHF-UCL.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IDA:BHF-UCL.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:0001558; P:regulation of cell growth; IEA:InterPro.
DR   GO; GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0034059; P:response to anoxia; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0070542; P:response to fatty acid; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0051385; P:response to mineralocorticoid; IEA:Ensembl.
DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; TAS:ProtInc.
DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   InterPro; IPR006207; Cys_knot_C.
DR   InterPro; IPR006208; Glyco_hormone_CN.
DR   InterPro; IPR009030; Growth_fac_rcpt_.
DR   InterPro; IPR000867; IGFBP-like.
DR   InterPro; IPR012395; IGFBP_CNN.
DR   InterPro; IPR017891; Insulin_GF-bd_Cys-rich_CS.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF00007; Cys_knot; 1.
DR   Pfam; PF00219; IGFBP; 1.
DR   Pfam; PF00090; TSP_1; 1.
DR   Pfam; PF00093; VWC; 1.
DR   PIRSF; PIRSF036495; IGFBP_rP_CNN; 1.
DR   SMART; SM00041; CT; 1.
DR   SMART; SM00121; IB; 1.
DR   SMART; SM00209; TSP1; 1.
DR   SMART; SM00214; VWC; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   SUPFAM; SSF82895; SSF82895; 1.
DR   PROSITE; PS01185; CTCK_1; 1.
DR   PROSITE; PS01225; CTCK_2; 1.
DR   PROSITE; PS00222; IGFBP_N_1; 1.
DR   PROSITE; PS51323; IGFBP_N_2; 1.
DR   PROSITE; PS50092; TSP1; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Complete proteome;
KW   Disulfide bond; DNA synthesis; Extracellular matrix; Glycoprotein;
KW   Heparin-binding; Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    349       Connective tissue growth factor.
FT                                /FTId=PRO_0000014402.
FT   DOMAIN       27     98       IGFBP N-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00653}.
FT   DOMAIN      101    167       VWFC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00220}.
FT   DOMAIN      198    243       TSP type-1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00210}.
FT   DOMAIN      256    330       CTCK. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00039}.
FT   REGION      247    349       Heparin-binding.
FT   CARBOHYD     28     28       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    225    225       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    256    293       {ECO:0000250}.
FT   DISULFID    273    307       {ECO:0000250}.
FT   DISULFID    284    323       {ECO:0000250}.
FT   DISULFID    287    325       {ECO:0000250}.
FT   DISULFID    292    329       {ECO:0000250}.
FT   VAR_SEQ     172    198       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_002460.
FT   VARIANT      83     83       H -> D (in dbSNP:rs7451102).
FT                                {ECO:0000269|PubMed:1293144,
FT                                ECO:0000269|PubMed:1654338,
FT                                ECO:0000269|PubMed:9054739,
FT                                ECO:0000269|Ref.12, ECO:0000269|Ref.4,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.6,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_027925.
FT   CONFLICT    175    175       V -> L (in Ref. 13; no nucleotide entry).
FT                                {ECO:0000305}.
SQ   SEQUENCE   349 AA;  38091 MW;  62CF878C7F57EC1F CRC64;
     MTAASMGPVR VAFVVLLALC SRPAVGQNCS GPCRCPDEPA PRCPAGVSLV LDGCGCCRVC
     AKQLGELCTE RDPCDPHKGL FCHFGSPANR KIGVCTAKDG APCIFGGTVY RSGESFQSSC
     KYQCTCLDGA VGCMPLCSMD VRLPSPDCPF PRRVKLPGKC CEEWVCDEPK DQTVVGPALA
     AYRLEDTFGP DPTMIRANCL VQTTEWSACS KTCGMGISTR VTNDNASCRL EKQSRLCMVR
     PCEADLEENI KKGKKCIRTP KISKPIKFEL SGCTSMKTYR AKFCGVCTDG RCCTPHRTTT
     LPVEFKCPDG EVMKKNMMFI KTCACHYNCP GDNDIFESLY YRKMYGDMA
//
